Aptamers Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033 | SomaLogic Inc., Aptagen LLC, Aptus Biotech, Vivonics Inc., GlyTech Inc., Novaptech Inc.

The aptamers market size has grown exponentially in recent years. It will grow from $2.16 billion in 2023 to $2.68 billion in 2024 at a compound annual growth rate (CAGR) of 23.8%. The growth in the historic period can be attributed to need for high-specificity binders, therapeutic potential, rise in personalized medicine, potential for therapeutic areas, antibody alternatives, diagnostic point-of-care (poc) devices.

The aptamers market size is expected to see exponential growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 24.5%. The growth in the forecast period can be attributed to increasing investment in life sciences, expansion in drug development, growth in cancer research, rapid detection in emergency settings, enhanced aptamer selection techniques, regulatory support. Major trends in the forecast period include advancements in selex technology, increasing applications in diagnostics, investment in aptamer research, technological integration with nanotechnology, awareness and education initiatives.

Market Overview -
Aptamers are short synthetic single-stranded oligonucleotides that fold into defined architectures and bind to target antigens such as proteins, molecules, peptides, cells, and tissues. It is used for the molecular recognition of their respective targets.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8156&type=smp

Growing Prevalence Of Chronic Respiratory Diseases Boosts Aptamers Market
The increasing prevalence of chronic respiratory diseases is expected to propel the growth of the aptamers market going forward. Chronic respiratory disease is when the airways narrow and swell and may produce extra mucus. It makes breathing challenging and causes coughing, shortness of breath, and wheezing when exhaling. Aptamers help detect the respiratory syncytial virus (RSV), help identify disease early, and provide treatment. For instance, in May 2021, according to a report shared by the Asthma and Allergy Foundation of America, a US-based non-profit organization, the number of Americans who have asthma will be over 25 million. Therefore, the rising prevalence of chronic respiratory diseases is driving the growth of the aptamers market.

Competitive Landscape -
Major companies operating in the aptamers market report are Aptamer Group Limited, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies Inc., AMS Biotechnology Ltd., Vivonics Inc., TriLink Biotechnologies LLC, Noxxon Pharma SE, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, Novaptech Inc., Maravai Lifesciences Inc., Bio-Techne Corporation, Creative Biolabs Inc., IBA Lifesciences GmbH, Aptabharat Innovations Pvt. Ltd., Profacgen Biotech Inc., Medi GmbH & Co. KG, Pure Biologics Sp. z o.o., Oak BioSciences Inc., Ophthotech Corporation, Novartis AG, NeoNeuro SAS, CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca plc, GlyTech Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies Inc., IVERIC bio Inc.

Technological Innovations Drive Advancements In The Aptamers Market
Technological innovations are the key trends gaining popularity in the aptamers market. Major companies operating in the market are introducing new technologies, such as artificial DNA aptamers, which are manufactured using adaptable and seamless technology to sustain their position in the market. For instance, in May 2021, NEC Corporation, a Japan-based multinational information technology and electronics corporation, developed artificial DNA aptamers that can bind to the novel coronavirus (SARS-CoV-2). With the help of adaptable and seamless technology, an aptamer can enter the body to target RBD, which is the key to infection and trap the virus by identifying the three-dimensional structure of the receptor-binding domain (RBD), forming a solid bond with it.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/aptamers-global-market-report

Key Segments -
The aptamers market covered in this report is segmented -
1) By Type: DNA Aptamers, XNA Aptamers, RNA Aptamers
2) By Technology: SELEX, X Aptamer, Maras Technique
3) By Application: Therapeutics Development, Research and Development, Diagnostic, Other Applications
4) By End User: Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Cathode-Ray Oscilloscope, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.